Records containing: Leukemia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-10Phase I/Ib Clinical Trial of Autologous CD22 Chimeric Antigen Receptor (CAR) T Cells Following Commercial CD19 CAR T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
-
CLINICAL_TRIALS study record update · 2026-02-09Cardiovascular Effects of Chimeric Antigen Receptor T-Cell (CART Cell) Therapy: An Observational Prospective Study
-
CLINICAL_TRIALS study record update · 2026-02-06Phase II Study of Cladribine Plus Low Dose Cytarabine (LDAC) Induction Followed By Consolidation With Cladribine Plus LDAC Alternating With Decitabine in Patients With Untreated Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
-
CLINICAL_TRIALS study record update · 2026-02-05Improving Communication With and Building a Stronger Medical Home Among Spanish-speaking Families in the Center for Cancer and Blood Disorders
-
CLINICAL_TRIALS study record update · 2026-02-05A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-02-05Mindfulness Interventions to Improve Health Activation, Coping, and Stress Among Childhood Cancer Survivors
-
CLINICAL_TRIALS study record update · 2026-02-03A Prospective, Single-Arm, Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia
-
CLINICAL_TRIALS study record update · 2026-02-02Observational Cohort Study of People Living With HIV Treated With CD19-directed CAR T Cell Therapy for B-cell Lymphoid Malignancies
-
CLINICAL_TRIALS study record update · 2026-01-28DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
-
CLINICAL_TRIALS study record update · 2026-01-27Combination of Lenalidomide and Rituximab in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL) as Initial Treatment or Subsequent Therapy
-
CLINICAL_TRIALS study record update · 2026-01-23INSPIRE-AYA: A Multicenter Interactive Survivorship Program to Improve Healthcare Resources for Adolescent and Young Adult (AYA) Cancer Survivors
-
CLINICAL_TRIALS study record update · 2026-01-23Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
-
CLINICAL_TRIALS study record update · 2026-01-22Integrated Cancer Repository for Cancer Research
-
CLINICAL_TRIALS study record update · 2026-01-21A Phase 1/2 Study of the Menin Inhibitor Revumenib With the CELMod Mezigdomide in Relapsed/Refractory KMT2A-rearanged, NPM1-mutant, and NUP98-rearranged Acute Leukemias
-
CLINICAL_TRIALS study record update · 2026-01-20cfDNA Assay Multicenter Prospective Observational Validation for Early Cancer Detection, Minimal Residual Disease, and Relapse
-
CLINICAL_TRIALS study record update · 2026-01-16A Phase 1, Open-label, Multicentre Study Evaluating the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics, and Preliminary Efficacy of CG009301 for Injection in Adult Subjects With Relapsed or Refractory Haematological Malignancies
-
CLINICAL_TRIALS study record update · 2026-01-15Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia
-
CLINICAL_TRIALS study record update · 2026-01-15Removing Transfusion Dependence as a Barrier to Hospice Enrollment
-
CLINICAL_TRIALS study record update · 2026-01-07Phase II Study of Palifermin With Leuprolide Acetate or Degarelix For the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2026-01-07Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
-
CLINICAL_TRIALS study record update · 2026-01-06Peer Support Group for AYA Allogeneic Stem Cell Transplant Recipients
-
CLINICAL_TRIALS study record update · 2026-01-06Immune Reconstitution Monitoring and Pneumococcal Vaccination (PCV-21) in Patients Treated With Chimeric Antigen Receptor T-Cells
-
CLINICAL_TRIALS study record update · 2026-01-02Cytokine-induced Memory-like Natural Killer Cell Therapy After Hematopoietic Stem Cell Transplantation for Eradication of Measurable Residual Disease, a Phase I/Ib Clinical Trial
-
CLINICAL_TRIALS study record update · 2025-12-30Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia. A Multicenter, Open-label, Phase II Trial
-
CLINICAL_TRIALS study record update · 2025-12-26Efficacy and Safety of Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies: A Prospective Randomized Study